Calcium channel blockers versus other classes of drugs for hypertension
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Calcium Channel Blockers Versus Other Classes of Drugs for Hypertension." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/434299/all/Calcium_channel_blockers_versus_other_classes_of_drugs_for_hypertension.
Calcium channel blockers versus other classes of drugs for hypertension. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434299/all/Calcium_channel_blockers_versus_other_classes_of_drugs_for_hypertension. Accessed April 27, 2025.
Calcium channel blockers versus other classes of drugs for hypertension. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434299/all/Calcium_channel_blockers_versus_other_classes_of_drugs_for_hypertension
Calcium Channel Blockers Versus Other Classes of Drugs for Hypertension [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 April 27]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/434299/all/Calcium_channel_blockers_versus_other_classes_of_drugs_for_hypertension.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Calcium channel blockers versus other classes of drugs for hypertension
ID - 434299
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/434299/all/Calcium_channel_blockers_versus_other_classes_of_drugs_for_hypertension
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -